Polyfunctional T cell responses are a hallmark of HIV-2 infection
- PMID: 18200635
- PMCID: PMC2362391
- DOI: 10.1002/eji.200737768
Polyfunctional T cell responses are a hallmark of HIV-2 infection
Abstract
HIV-2 is distinguished clinically and immunologically from HIV-1 infection by delayed disease progression and maintenance of HIV-specific CD4(+) T cell help in most infected subjects. Thus, HIV-2 provides a unique natural human model in which to investigate correlates of immune protection against HIV disease progression. Here, we report a detailed assessment of the HIV-2-specific CD4(+) and CD8(+) T cell response compared to HIV-1, using polychromatic flow cytometry to assess the quality of the HIV-specific T cell response by measuring IFN-gamma, IL-2, TNF-alpha, MIP-1beta, and CD107a mobilization (degranulation) simultaneously following Gag peptide stimulation. We find that HIV-2-specific CD4(+) and CD8(+) T cells are more polyfunctional that those specific for HIV-1 and that polyfunctional HIV-2-specific T cells produce more IFN-gamma and TNF-alpha on a per-cell basis than monofunctional T cells. Polyfunctional HIV-2-specific CD4(+) T cells were generally more differentiated and expressed CD57, while there was no association between function and phenotype in the CD8(+) T cell fraction. Polyfunctional HIV-specific T cell responses are a hallmark of non-progressive HIV-2 infection and may be related to good clinical outcome in this setting.
Figures





Similar articles
-
Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection.J Immunol. 2006 Jun 1;176(11):6973-81. doi: 10.4049/jimmunol.176.11.6973. J Immunol. 2006. PMID: 16709858
-
HIV-specific T-cell responses detected in the genital tract of chronically HIV-infected women are largely monofunctional.Immunology. 2013 Jul;139(3):342-51. doi: 10.1111/imm.12084. Immunology. 2013. PMID: 23374084 Free PMC article.
-
HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment.J Immunol. 2003 Apr 15;170(8):4403-10. doi: 10.4049/jimmunol.170.8.4403. J Immunol. 2003. PMID: 12682278
-
Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection.Springer Semin Immunopathol. 2006 Nov;28(3):209-19. doi: 10.1007/s00281-006-0025-4. Epub 2006 Aug 25. Springer Semin Immunopathol. 2006. PMID: 16932955 Review. No abstract available.
-
Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis.Rev Med Virol. 2013 Jul;23(4):221-40. doi: 10.1002/rmv.1739. Epub 2013 Feb 26. Rev Med Virol. 2013. PMID: 23444290 Review.
Cited by
-
Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease.PLoS Pathog. 2009 Nov;5(11):e1000667. doi: 10.1371/journal.ppat.1000667. Epub 2009 Nov 20. PLoS Pathog. 2009. PMID: 19936055 Free PMC article.
-
Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination.Cancer Immunol Immunother. 2009 Oct;58(10):1609-26. doi: 10.1007/s00262-009-0670-2. Epub 2009 Feb 17. Cancer Immunol Immunother. 2009. PMID: 19221745 Free PMC article.
-
Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection.J Immunol. 2012 Mar 1;188(5):2198-206. doi: 10.4049/jimmunol.1102813. Epub 2012 Jan 27. J Immunol. 2012. PMID: 22287716 Free PMC article.
-
Immunogenicity and vaccine efficacy of Actinobacillus pleuropneumoniae-derived extracellular vesicles as a novel vaccine candidate.Virulence. 2025 Dec;16(1):2453818. doi: 10.1080/21505594.2025.2453818. Epub 2025 Jan 20. Virulence. 2025. PMID: 39831520 Free PMC article.
-
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination.RMD Open. 2022 Sep;8(2):e002293. doi: 10.1136/rmdopen-2022-002293. RMD Open. 2022. PMID: 36104115 Free PMC article.
References
-
- Poulsen AG, Aaby P, Larsen O, Jensen H, Naucler A, Lisse IM, Christiansen CB, et al. 9-year HIV-2-associated mortality in an urban community in Bissau, West Africa. Lancet. 1997;349:911–914. - PubMed
-
- Schim van der Loeff MF, Jaffar S, Aveika AA, Sabally S, Corrah T, Harding E, Alabi A, et al. Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia. Aids. 2002;16:1775–1783. - PubMed
-
- Ariyoshi K, Jaffar S, Alabi AS, Berry N, Schim van der Loeff M, Sabally S, N'Gom PT, et al. Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa. Aids. 2000;14:339–344. - PubMed
-
- Berry N, Jaffar S, Schim van der Loeff M, Ariyoshi K, Harding E, N'Gom PT, Dias F, et al. Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers. AIDS Res. Hum. Retroviruses. 2002;18:1167–1173. - PubMed
-
- Ariyoshi K, Berry N, Wilkins A, Ricard D, Aaby P, Naucler A, Ngom PT, et al. A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa. J. Infect. Dis. 1996;173:245–248. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials